Literature DB >> 33489209

Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases.

Sreethish Sasi1, Mohamed A Yassin2, Sadat Kamran3, Vazgen Mnatsakanyan3.   

Abstract

Screening for MG in patients with PV positive for JAK2V617F mutation can help in early diagnosis and treatment, resulting in a significant reduction in morbidity and mortality.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  interferon‐alpha; myasthenia gravis; paraneoplastic syndromes; polycythemia vera

Year:  2020        PMID： 33489209      PMCID： PMC7813032          DOI： 10.1002/ccr3.3574

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN： 2050-0904


  14 in total

1.  Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis.

Authors:  P Kumar; P Jain; H Menon; P Purvish
Journal:  Ann Oncol       Date:  2007-04       Impact factor: 32.976

2.  Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity.

Authors:  H Bolay; R Karabudak; C Aybay; H Candemir; K Varli; T Imir; E Kansu
Journal:  J Neuroimmunol       Date:  1998-03-01       Impact factor: 3.478

Review 3.  The epidemiology of myasthenia gravis in Arab countries: a systematic review.

Authors:  Hani T S Benamer; Amin Bredan
Journal:  Muscle Nerve       Date:  2014-11-22       Impact factor: 3.217

4.  Development of myasthenia gravis after interferon alpha therapy.

Authors:  I G Gurtubay; G Morales; O Aréchaga; J Gállego
Journal:  Electromyogr Clin Neurophysiol       Date:  1999-03

5.  Myasthenia gravis during interferon alfa therapy.

Authors:  A P Batocchi; A Evoli; S Servidei; M T Palmisani; F Apollo; P Tonali
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

6.  Chronic myeloid leukemia with an unusual paraneoplastic syndrome.

Authors:  Namita Sharma; Harsh Dua; Deepak Rosha
Journal:  J Assoc Physicians India       Date:  2012-08

7.  Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases.

Authors:  U Dührsen; W Augener; T Zwingers; G Brittinger
Journal:  Br J Haematol       Date:  1987-10       Impact factor: 6.998

8.  TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries.

Authors:  Anna Turkina; Jianxiang Wang; Vikram Mathews; Guray Saydam; Chul Won Jung; Hani Hassan Al Hashmi; Mohamed Yassin; Solenn Le Clanche; Darko Miljkovic; Cassandra Slader; Timothy P Hughes
Journal:  Br J Haematol       Date:  2020-03-30       Impact factor: 6.998

9.  Myasthenia gravis-like syndrome presenting as a component of the paraneoplastic syndrome of lung adenocarcinoma in a nonsmoker.

Authors:  Sahar Eivaz-Mohammadi; Fernando Gonzalez-Ibarra; Hesam Hekmatjou; Rao Mikkilineni; Amit Patel; Amer K Syed
Journal:  Case Rep Oncol Med       Date:  2014-07-23

10.  A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm.

Authors:  Sreethish Sasi; Mohamed A Yassin; Afraa M Fadul
Journal:  Case Rep Oncol       Date:  2020-06-26
View more
  1 in total

1.  Myasthenia Gravis and Myeloproliferative Neoplasms - Mere Association or Paraneoplastic Neurologic Syndrome: A Mini-Review.

Authors:  Sreethish Sasi; Mouhand Mohamed; P Chitrambika; Mohamed Yassin
Journal:  Acta Biomed       Date:  2022-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.